Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment ...

Antidepressant side effects differ greatly depending on the drug, study finds

Millions of Americans take antidepressants. And like all medication, they come with side effects. Researchers studied 30 ...
Monthly Prescribing Reference

Sublingual Cyclobenzaprine Shows Clinically Meaningful Effects on Pain, Sleep Measures in Fibromyalgia

ATLANTA — Investigational new drug TNX-102 SL may provide clinically meaningful effects on function, fatigue, and sleep quality in patients with fibromyalgia, according to research results presented ...
WebMD

FDA Approves New Non-Opioid, Once-Daily Bedtime Tablet for Fibromyalgia Pain and Sleep Disturbance

Tonmya (cyclobenzaprine) is a non-opioid medicine approved by the FDA to treat fibromyalgia in adults. It’s taken once daily at bedtime as a small tablet that dissolves under your tongue. It provides ...
MassLive

Nationwide recall alert: Pill bottle mix-up could lead to serious reactions

A pharmaceutical company is recalling one of its products after discovering that the pill bottle could be filled with the wrong medication. According to the Food and Drug Administration (FDA), Unichem ...
MarketWatch

Tonix Pharmaceuticals Announces FDA Approval of Tonmya(TM) (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...
TipRanks on MSN

Tonix Pharmaceuticals presents data on Tonmya at ACR Convergence

Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology ...